Paul Smith
Impact in
- Epidemiology top 5%
- Autophagy in Disease and Therapy
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- RNA modifications and cancer 4
- DNA Repair Mechanisms 2
- Ubiquitin and proteasome pathways 2
- Metabolism, Diabetes, and Cancer 2
- Epigenetics and DNA Methylation 2
- Oncology 8
- Cancer-related Molecular Pathways 5
- Co-authors
- Tim Crook (4 shared papers)Paul R. Harrison (1 shared paper)Simon Wilkinson (1 shared paper)Milena Gasco (1 shared paper)Kevin M. Ryan (1 shared paper)Diane Crighton (1 shared paper)Nelofer Syed (1 shared paper)Jim O’Prey (1 shared paper)
- Journals
- Cancer Research (4 papers)Oncogene (2 papers)Biochemical Journal (2 papers)Epilepsia (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Paul Smith
29 papers receiving 1.9k citations
Paul Smith's Hit Papers
Peers
Comparison fields: 5 of 97
- Epidemiology 766
- Cancer Research 329
- Geriatrics and Gerontology 74
- Physiology 100
- Oncology 434
Countries citing papers authored by Paul Smith
This map shows the geographic impact of Paul Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Smith more than expected).
Fields of papers citing papers by Paul Smith
This network shows the impact of papers produced by Paul Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Smith. The network helps show where Paul Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | DRAM, a p53-Induced Modulator of Autophagy, Is Critical for Apoptosis Hit paper breakdown → | 2006 | 1155 |
| 2 | 1998 | 144 | |
| 3 | Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro. | 2003 | 98 |
| 4 | 1999 | 85 | |
| 5 | 1987 | 68 | |
| 6 | 2021 | 60 | |
| 7 | 2010 | 50 | |
| 8 | 2009 | 49 | |
| 9 | 2005 | 40 | |
| 10 | 2009 | 36 | |
| 11 | 1998 | 32 | |
| 12 | 2018 | 30 | |
| 13 | 2024 | 24 | |
| 14 | 1996 | 22 | |
| 15 | 2006 | 21 | |
| 16 | 2009 | 16 | |
| 17 | 2015 | 15 | |
| 18 | 2005 | 14 | |
| 19 | 2012 | 11 | |
| 20 | 2019 | 9 |
About Paul Smith
Paul Smith is a scholar working on Molecular Biology, Oncology, Cancer Research, Epidemiology and Surgery, having authored 32 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), RNA modifications and cancer (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), DNA Repair Mechanisms (2 papers), Ubiquitin and proteasome pathways (2 papers), Neurogenesis and neuroplasticity mechanisms (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Epidemiology (766 citations), Cancer Research (329 citations), Geriatrics and Gerontology (74 citations), Physiology (100 citations) and Oncology (434 citations). Paul Smith has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Tim Crook, Paul R. Harrison, Simon Wilkinson, Milena Gasco, Kevin M. Ryan, Diane Crighton, Nelofer Syed, Jim O’Prey, Ornella Garrone and M. Rufus Crompton. Their work appears in journals such as Cancer Research, Oncogene, Biochemical Journal, Epilepsia and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.